|Bid||0.23 x 10000|
|Ask||0.29 x 10000|
|Day's Range||37.00 - 37.00|
|52 Week Range||6.10 - 37.50|
|Beta (5Y Monthly)||0.46|
|PE Ratio (TTM)||3.18|
|Earnings Date||Aug 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CAPS
ALSIP, IL / ACCESSWIRE / June 21, 2022/Capstone Holding Corp. (OTCQB:CAPS) ("the Company")EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON STOCKOn June 15, 2022, BP Peptides, LLC ("Brookstone") exercised its right to convert $1,938,746 of accrued interest and debt from its Senior Secured Note(s) into 78,333 shares of the Company's Common Stock (exercise price of $24.
ALSIP, IL / ACCESSWIRE / December 2, 2021 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company"):The Annual Meeting of Stockholders of Capstone Therapeutics Corp.